A recent study by Pucci and colleagues identified 17 glycosyltransferases associated with poor prognosis in BC, with ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 (ST6GALNAC4) emerging as one of the top candidates [77]. Here, ST6GALNAC4 is linked to breast cancer.